Paul Bingham and colleagues continue to investigate the wide potential of CPI-613, especially its efficacy when used in concert with other drugs to treat cancer.
Ann Lin '18 and Chris Giuliano '18 co-authored a paper that was published in the influential interdisciplinary medical journal Science Translational Medicine.